These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15578267)

  • 41. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
    Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
    Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice.
    Lam P; Wang R; Ling V
    Biochemistry; 2005 Sep; 44(37):12598-605. PubMed ID: 16156672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
    Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
    Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
    Vallejo M; Briz O; Serrano MA; Monte MJ; Marin JJ
    J Hepatol; 2006 Jun; 44(6):1150-7. PubMed ID: 16458994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.
    Chen HL; Chen HL; Yuan RH; Wu SH; Chen YH; Chien CS; Chou SP; Wang R; Ling V; Chang MH
    J Cell Mol Med; 2012 Nov; 16(11):2679-89. PubMed ID: 22564513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
    Marrone J; Danielli M; Gaspari CI; Marinelli RA
    IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
    Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
    Imagawa K; Takayama K; Isoyama S; Tanikawa K; Shinkai M; Harada K; Tachibana M; Sakurai F; Noguchi E; Hirata K; Kage M; Kawabata K; Sumazaki R; Mizuguchi H
    Sci Rep; 2017 Feb; 7():41806. PubMed ID: 28150711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.
    Hrycay E; Forrest D; Liu L; Wang R; Tai J; Deo A; Ling V; Bandiera S
    Mol Cell Biochem; 2014 Apr; 389(1-2):119-32. PubMed ID: 24399466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
    Byrne JA; Strautnieks SS; Mieli-Vergani G; Higgins CF; Linton KJ; Thompson RJ
    Gastroenterology; 2002 Nov; 123(5):1649-58. PubMed ID: 12404239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Morgan RE; Trauner M; van Staden CJ; Lee PH; Ramachandran B; Eschenberg M; Afshari CA; Qualls CW; Lightfoot-Dunn R; Hamadeh HK
    Toxicol Sci; 2010 Dec; 118(2):485-500. PubMed ID: 20829430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
    Hayashi H; Sugiyama Y
    Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
    Fattinger K; Funk C; Pantze M; Weber C; Reichen J; Stieger B; Meier PJ
    Clin Pharmacol Ther; 2001 Apr; 69(4):223-31. PubMed ID: 11309550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.
    Lee JM; Trauner M; Soroka CJ; Stieger B; Meier PJ; Boyer JL
    Gastroenterology; 2000 Jan; 118(1):163-72. PubMed ID: 10611165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
    Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
    Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.